Asahi Kasei Medical
  • Site Map
  • Contact Us
  • Font size: Small
  • Font size: Medium
  • Font size: Large
  • Home
  • Our Approach to Business
  • Corporate Information
  • News
  • Products
  • Patients and Families

Cascadeflo EC: Minimal albumin loss & effective removal of target substances by selection of appropriate filter among the four different pore size models

Featured References

Julius et al.
Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and Lipidfiltration.
J Clin Apher. 22:215-23, 2007.

References

Julius et al:
Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP.
Int J Artif Organs. 25:1180-8, 2002.
Klingel et al:
From membrane differential filtration to lipidfiltration: technological progress in low-density lipoprotein apheresis.
Ther Apher Dial. 7:350-8, 2003.
Klingel et al:
Lipidfiltration - safe and effective methodology to perform lipid-apheresis.
Transfusion and Apheresis Science. 30:245-254, 2004.
Taniguchi et al:
Impact of double-filtration plasmapheresis in combination with interferon and ribavirin in living donor liver transplant recipients with hepatitis C.
Transplantation. 81:1747-9, 2006.
Fujiwara et al:
Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load.
Hepatol Res. 37:701-10, 2007.
Yu et al:
A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
J Clin Rheumatol. 13:193-8, 2007.
Julius et al:
Dextran-sulfate-adsorption of atherosclerotic lipoproteins from whole blood or separated plasma for lipid-apheresis--comparison of performance characteristics with DALI and Lipidfiltration.
J Clin Apher. 22:215-23, 2007.
Kaneko et al:
Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C.
Hepatol Res. 40:1072-1081, 2010.
Fernández-Fuertes et al:
Low-density lipoprotein apheresis using double filtration plasmapheresis: 27-month use in a child with homozygous familial hypercholesterolemia.
Ther Apher Dial. 14:484-5, 2010.
Liu et al:
Successful treatment of patients with systemic lupus erythematosus complicated with autoimmune thyroid disease using double-filtration plasmapheresis: a retrospective study.
J Clin Apher. 26:174-80, 2011.

Trademark
Cascadeflo is a trademark of Asahi Kasei Medical Co., Ltd.

Download

Cascadeflo EC

Contact Us

Please feel free to send us any questions you may have about our products and support.

Contact Us
Note: It might be required in your country that medical devices shall be officially registered and/or approved by an authorized organization. Please contact our representative in your region or contact us to confirm whether the listed products are approved for use. These information may contain general information on medical-related topics and is not meant to provide specialist advice or instructions concerning the products and services sold by Asahi Kasei Medical. Please contact us directly for special inquiries. You should not use this information for diagnosing a health problem or disease but should always consult your own physician.Contact us

Top of page